A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh(αK): A phase II study

Authors:

Abstract
No abstract available
Funding Information
  • Ministry of Economic Affairs, ROC (106-EC-17-A22-I5-0-0010)

This publication has 30 references indexed in Scilit: